{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:51:50Z","timestamp":1791910310593,"version":"4.3.4"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017633","name":"Shanghai Anti Cancer Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003347","name":"Fudan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["apjon.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Asia-Pacific Journal of Oncology Nursing"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.apjon.2026.100923","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T17:01:06Z","timestamp":1771434066000},"page":"100923","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Development and internal-external validation of a risk prediction model for acute pain after HAIC for patients with liver cancer using logistic regression and XGBoost algorithm"],"prefix":"10.1016","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-5556-3432","authenticated-orcid":false,"given":"Jiacheng","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yina","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawei","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghui","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7051-9399","authenticated-orcid":false,"given":"Wenjuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.apjon.2026.100923_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"10.1016\/j.apjon.2026.100923_bib2","first-page":"532","article-title":"Clinical practice guideline for primary liver Cancer(2024 edition)","volume":"15","year":"2024","journal-title":"Med J Peking Union Med Coll Hosp"},{"issue":"1","key":"10.1016\/j.apjon.2026.100923_bib3","doi-asserted-by":"crossref","first-page":"20","DOI":"10.5582\/bst.2022.01061","article-title":"The clinical management of hepatocellular carcinoma worldwide: a concise review and comparison of current guidelines: 2022 update","volume":"16","author":"Wen","year":"2022","journal-title":"Biosci Trends"},{"issue":"26","key":"10.1016\/j.apjon.2026.100923_bib4","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000020745","article-title":"Effects of hepatic arterial infusion chemotherapy in the treatment of hepatocellular carcinoma","volume":"99","author":"Long","year":"2020","journal-title":"Medicine (Baltim)"},{"issue":"2","key":"10.1016\/j.apjon.2026.100923_bib5","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1080\/17843286.2022.2076791","article-title":"Hepatic arterial infusion chemotherapy versus transarterial chemoembolization for patients with unresectable hepatocellular carcinoma: a systematic review and meta-analysis","volume":"78","author":"Kong","year":"2023","journal-title":"Acta Clin Belg"},{"key":"10.1016\/j.apjon.2026.100923_bib6","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s40880-017-0251-2","article-title":"Hepatic artery infusion chemotherapy using mFOLFOX versus transarterial chemoembolization for massive unresectable hepatocellular carcinoma: a prospective non-randomized study","volume":"36","author":"He","year":"2017","journal-title":"Chin J Cancer"},{"issue":"2","key":"10.1016\/j.apjon.2026.100923_bib7","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1200\/JCO.21.00608","article-title":"Hepatic arterial infusion of oxaliplatin, fluorouracil, and leucovorin versus transarterial chemoembolization for large hepatocellular carcinoma: a randomized phase III trial","volume":"40","author":"Li","year":"2022","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.apjon.2026.100923_bib8","first-page":"80","article-title":"Multiple linear regression analysis of factors related to the hospitalization days in HCC patients after transcatheter hepatic arterial chemoembolization","volume":"24","author":"Zang","year":"2015","journal-title":"J Interv Radiol"},{"issue":"10","key":"10.1016\/j.apjon.2026.100923_bib9","first-page":"943","article-title":"Expert consensus on the interventional perioperative pain management for patients with liver malignancy (2022 Edition)","volume":"31","author":"Wang","year":"2022","journal-title":"J Interv Radiol"},{"issue":"1","key":"10.1016\/j.apjon.2026.100923_bib10","first-page":"31","article-title":"Shanghai expert consensus on perioperative analgesia managment in general surgery patients(2020 edition)","volume":"41","author":"Gu","year":"2021","journal-title":"Chin J Pract Surg"},{"issue":"3","key":"10.1016\/j.apjon.2026.100923_bib11","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/nhs.12853","article-title":"Predictors of maximal postoperative pain at rest in adult patients undergoing elective surgery - a multicenter observational study","volume":"23","author":"Tomaszek","year":"2021","journal-title":"Nurs Health Sci"},{"issue":"9","key":"10.1016\/j.apjon.2026.100923_bib12","first-page":"1338","article-title":"Development and validation of a risk prediction model for acute postsurgical pain in patients after hepatectomy","volume":"25","author":"Chen","year":"2025","journal-title":"Chin Nurs Manag"},{"key":"10.1016\/j.apjon.2026.100923_bib13","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/5203166","article-title":"Construction and validation of prediction model of severe abdominal pain post-transarterial chemoembolization in patients with HBV-associated primary liver cancer","volume":"2022","author":"Yang","year":"2022","journal-title":"Comput Math Methods Med"},{"key":"10.1016\/j.apjon.2026.100923_bib14","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2147\/JHC.S494668","article-title":"Risk factors and predictive analysis of acute severe abdominal pain after hepatic artery infusion chemotherapy in patients with hepatocellular carcinoma","volume":"12","author":"Li","year":"2025","journal-title":"J Hepatocell Carcinoma"},{"issue":"2","key":"10.1016\/j.apjon.2026.100923_bib15","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/s10637-020-01009-x","article-title":"Determinants of pain in advanced HCC patients recieving hepatic artery infusion chemotherapy","volume":"39","author":"Wu","year":"2021","journal-title":"Invest N Drugs"},{"key":"10.1016\/j.apjon.2026.100923_bib16","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-078378","article-title":"TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods","volume":"385","author":"Collins","year":"2024","journal-title":"The BMJ"},{"issue":"6","key":"10.1016\/j.apjon.2026.100923_bib17","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.pmn.2025.08.005","article-title":"Exploring established cut-off points for pain levels in the numeric rating scale: insights from a literature overview","volume":"26","author":"Monticelli","year":"2025","journal-title":"Pain Manag Nurs"},{"issue":"8","key":"10.1016\/j.apjon.2026.100923_bib18","first-page":"608","article-title":"Advances in the pharmacologic management of acute perioperative pain","volume":"23","author":"Xie","year":"2017","journal-title":"Chin J Pain Med"},{"issue":"4","key":"10.1016\/j.apjon.2026.100923_bib19","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1188\/03.ONF.601-606","article-title":"Symptoms experience: a concept analysis","volume":"30","author":"Armstrong","year":"2003","journal-title":"Oncol Nurs Forum"},{"issue":"4","key":"10.1016\/j.apjon.2026.100923_bib20","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4","article-title":"Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors","volume":"15","author":"Harrell","year":"1996","journal-title":"Stat Med"},{"key":"10.1016\/j.apjon.2026.100923_bib21","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jclinepi.2021.02.011","article-title":"External validation of clinical prediction models: simulation-based sample size calculations were more reliable than rules-of-thumb","volume":"135","author":"Snell","year":"2021","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.apjon.2026.100923_bib22","article-title":"Evaluation of clinical prediction models (part 2): how to undertake an external validation study","volume":"384","author":"Riley","year":"2024","journal-title":"The BMJ"},{"issue":"8","key":"10.1016\/j.apjon.2026.100923_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.apjon.2024.100546","article-title":"Machine learning risk prediction model for bloodstream infections related to totally implantable venous access ports in patients with cancer","volume":"11","author":"Wang","year":"2024","journal-title":"Asia Pac J Oncol Nurs"},{"key":"10.1016\/j.apjon.2026.100923_bib24","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-078276","article-title":"Developing clinical prediction models: a step-by-step guide","volume":"386","author":"Efthimiou","year":"2024","journal-title":"The BMJ"},{"issue":"9","key":"10.1016\/j.apjon.2026.100923_bib25","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41568-021-00383-9","article-title":"The immunological and metabolic landscape in primary and metastatic liver cancer","volume":"21","author":"Li","year":"2021","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"10.1016\/j.apjon.2026.100923_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.7018","article-title":"Impact of inflammation and the immune system on hepatocellular carcinoma recurrence after hepatectomy","volume":"13","author":"She","year":"2024","journal-title":"Cancer Med"},{"issue":"4","key":"10.1016\/j.apjon.2026.100923_bib27","article-title":"Liver manipulation during liver surgery in humans is associated with hepatocellular damage and hepatic inflammation","volume":"33","author":"Ma van den","year":"2013","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"issue":"22","key":"10.1016\/j.apjon.2026.100923_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232214426","article-title":"Inflammation and infection in pain and the role of GPR37","volume":"23","author":"Zhang","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"7","key":"10.1016\/j.apjon.2026.100923_bib29","first-page":"28","article-title":"Guidelines for the rational use of medications in hypertension (2nd version)","volume":"9","year":"2017","journal-title":"Chin J Front Med Sci"},{"issue":"18","key":"10.1016\/j.apjon.2026.100923_bib30","first-page":"2470","article-title":"Study on the doses of oxaliplatin in patients with hepatocellular carcinoma after transcatheter arterial chemoembolization","volume":"27","author":"Li","year":"2016","journal-title":"China Pharm"},{"issue":"6","key":"10.1016\/j.apjon.2026.100923_bib31","first-page":"951","article-title":"Efficacy of different doses of oxaliplatin in transhepatic arterial chemoembolization for primary hepatocellular carcinoma in elderly people","volume":"32","author":"Zhang","year":"2015","journal-title":"J Guangxi Med Univ"},{"key":"10.1016\/j.apjon.2026.100923_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.929141","article-title":"Efficacy and safety of atezolizumab plus bevacizumab combined with hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma","volume":"13","author":"Xin","year":"2022","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.apjon.2026.100923_bib33","doi-asserted-by":"crossref","DOI":"10.4240\/wjgs.v17.i4.101439","article-title":"Novel multimodal analgesic regimen for perioperative pain management after hepatic artery infusion chemotherapy in patients with advanced hepatocellular carcinoma","volume":"17","author":"Yan","year":"2025","journal-title":"World J Gastrointest Surg"},{"key":"10.1016\/j.apjon.2026.100923_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fsurg.2024.1378307","article-title":"Effect of lidocaine pumped through hepatic artery to relieve pain of hepatic artery infusion chemotherapy","volume":"11","author":"Zhang","year":"2024","journal-title":"Front Surg"}],"container-title":["Asia-Pacific Journal of Oncology Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2347562526000739?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2347562526000739?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:26:00Z","timestamp":1791908760000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2347562526000739"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":34,"alternative-id":["S2347562526000739"],"URL":"https:\/\/doi.org\/10.1016\/j.apjon.2026.100923","relation":{},"ISSN":["2347-5625"],"issn-type":[{"value":"2347-5625","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and internal-external validation of a risk prediction model for acute pain after HAIC for patients with liver cancer using logistic regression and XGBoost algorithm","name":"articletitle","label":"Article Title"},{"value":"Asia-Pacific Journal of Oncology Nursing","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apjon.2026.100923","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of Asian Oncology Nursing Society.","name":"copyright","label":"Copyright"}],"article-number":"100923"}}